Ryan Clark

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 11,666,557
- Issue date Jun 6, 2023
- TEMPEST THERAPEUTICS, INC.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfide alkyl compounds for HBV treatment
- Patent number 10,710,959
- Issue date Jul 14, 2020
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 10,568,871
- Issue date Feb 25, 2020
- TEMPEST THERAPEUTICS, INC.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridyl reverse sulfonamides for HBV treatment
- Patent number 10,428,041
- Issue date Oct 1, 2019
- Novira Therapeutics, Inc.
- Ryan C. Clark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds as IRAK inhibitors and uses thereof
- Patent number 10,392,375
- Issue date Aug 27, 2019
- Merck Patent GmbH
- Catherine Jorand-Lebrun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfide alkyl compounds for HBV treatment
- Patent number 10,196,351
- Issue date Feb 5, 2019
- Novira Therapeutics, Inc.
- Austin Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridyl reverse sulfonamides for HBV treatment
- Patent number 10,160,742
- Issue date Dec 25, 2018
- Novira Therapeutics, Inc.
- Ryan C. Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds as IRAK inhibitors and uses thereof
- Patent number 10,059,701
- Issue date Aug 28, 2018
- Merck Patent GmbH
- Catherine Jorand-Lebrun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polycyclic compounds as lysophosphatidic acid receptor antagonists
- Patent number 10,000,456
- Issue date Jun 19, 2018
- Amira Pharmaceuticals, Inc.
- Ryan Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds as IRAK inhibitors and uses thereof
- Patent number 9,969,710
- Issue date May 15, 2018
- Merck Patent GmbH
- Catherine Jorand-Lebrun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridyl reverse sulfonamides for HBV treatment
- Patent number 9,765,050
- Issue date Sep 19, 2017
- Novira Therapeutics, Inc.
- Ryan C. Clark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 9,676,754
- Issue date Jun 13, 2017
- Inception 2, Inc.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as lysophosphatidic acid receptor antagonists
- Patent number 9,624,182
- Issue date Apr 18, 2017
- Amira Pharmaceuticals, Inc.
- Thomas J. Seiders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfide alkyl compounds for HBV treatment
- Patent number 9,597,332
- Issue date Mar 21, 2017
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 9,505,728
- Issue date Nov 29, 2016
- Inception 2, Inc.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as lysophosphatidic acid receptor antagonists
- Patent number 9,090,573
- Issue date Jul 28, 2015
- Amira Pharmaceuticals, Inc.
- Thomas J Seiders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polycyclic compounds as lysophosphatidic acid receptor antagonists
- Patent number 8,778,983
- Issue date Jul 15, 2014
- Amira Pharmaceuticals, Inc.
- Ryan Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polycyclic compounds as lysophosphatidic acid receptor antagonists
- Patent number 8,664,220
- Issue date Mar 4, 2014
- Amira Pharmaceuticals, Inc.
- Ryan Clark
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20240041837
- Publication date Feb 8, 2024
- Tempest Therapeutics, Inc.
- Nicholas Simon STOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREX1 INHIBITORS AND USES THEREOF
- Publication number 20230234943
- Publication date Jul 27, 2023
- Tempest Therapeutics, Inc.
- Thomas Walter DUBENSKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINOAZINE AMIDES
- Publication number 20210363152
- Publication date Nov 25, 2021
- HOFFMANN-LA ROCHE INC.
- Jill Melissa Baccei
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20200138790
- Publication date May 7, 2020
- Tempest Therapeutics, Inc.
- Nicholas Simon STOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
- Publication number 20190202780
- Publication date Jul 4, 2019
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyridyl Reverse Sulfonamides For HBV Treatment
- Publication number 20190152940
- Publication date May 23, 2019
- Novira Therapeutics, Inc.
- Ryan C. Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20180237426
- Publication date Aug 23, 2018
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20180237413
- Publication date Aug 23, 2018
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyridyl Reverse Sulfonamides For HBV Treatment
- Publication number 20180051000
- Publication date Feb 22, 2018
- Novira Therapeutics, Inc.
- Ryan C. Clark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
- Publication number 20170298014
- Publication date Oct 19, 2017
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20170239223
- Publication date Aug 24, 2017
- INCEPTION 2, INC.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20170081307
- Publication date Mar 23, 2017
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20170081317
- Publication date Mar 23, 2017
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDYL REVERSE SULFONAMIDES FOR HBV TREATMENT
- Publication number 20160185748
- Publication date Jun 30, 2016
- Novira Therapeutics, Inc.
- Ryan C. Clark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
- Publication number 20160151375
- Publication date Jun 2, 2016
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20150344446
- Publication date Dec 3, 2015
- INCEPTION 2, INC.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
- Publication number 20150329502
- Publication date Nov 19, 2015
- AMIRA PHARMACEUTICALS, INC.
- Thomas J. Seiders
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20150080412
- Publication date Mar 19, 2015
- INCEPTION 2, INC.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
- Publication number 20140256744
- Publication date Sep 11, 2014
- Ryan Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
- Publication number 20130072490
- Publication date Mar 21, 2013
- AMIRA PHARMACEUTICALS INC.
- Ryan Clark
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
- Publication number 20120289522
- Publication date Nov 15, 2012
- Amira Pharmaceuticals INC.
- Thomas J. Seiders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
- Publication number 20120004233
- Publication date Jan 5, 2012
- Amira Pharmaceuticals, Inc.
- Brian Andrew Stearns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
- Publication number 20110312974
- Publication date Dec 22, 2011
- Amira Pharmaceuticals, Inc.
- John Howard Hutchinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tricyclic Antagonists of Prostaglandin D2 Receptors
- Publication number 20110112134
- Publication date May 12, 2011
- Amira Pharmaceuticals, Inc.
- John Howard Hutchinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
- Publication number 20110082164
- Publication date Apr 7, 2011
- Amira Pharmaceuticals, Inc.
- Ryan CLARK
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Triazolone compounds and uses thereof

Sulfide alkyl compounds for HBV treatment

Triazolone compounds and uses thereof

Pyridyl reverse sulfonamides for HBV treatment

Heteroaryl compounds as IRAK inhibitors and uses thereof

Sulfide alkyl compounds for HBV treatment

Pyridyl reverse sulfonamides for HBV treatment

Heteroaryl compounds as IRAK inhibitors and uses thereof

Polycyclic compounds as lysophosphatidic acid receptor antagonists

Heteroaryl compounds as IRAK inhibitors and uses thereof

Pyridyl reverse sulfonamides for HBV treatment

Triazolone compounds and uses thereof

Compounds as lysophosphatidic acid receptor antagonists

Sulfide alkyl compounds for HBV treatment

Triazolone compounds and uses thereof

Compounds as lysophosphatidic acid receptor antagonists

Polycyclic compounds as lysophosphatidic acid receptor antagonists

Polycyclic compounds as lysophosphatidic acid receptor antagonists

Patents Applicationslast 30 patents

TRIAZOLONE COMPOUNDS AND USES THEREOF

TREX1 INHIBITORS AND USES THEREOF

AMINOAZINE AMIDES

TRIAZOLONE COMPOUNDS AND USES THEREOF

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT

Pyridyl Reverse Sulfonamides For HBV Treatment

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

Pyridyl Reverse Sulfonamides For HBV Treatment

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT

TRIAZOLONE COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

PYRIDYL REVERSE SULFONAMIDES FOR HBV TREATMENT

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT

TRIAZOLONE COMPOUNDS AND USES THEREOF

COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

TRIAZOLONE COMPOUNDS AND USES THEREOF

POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

TRICYCLIC COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Tricyclic Antagonists of Prostaglandin D2 Receptors

POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS